Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Gonadorelin

GnRH, Luteinizing Hormone-Releasing Hormone, LHRH, Factrel

Quick Stats
Studies 192
Trials 100
Unknown NA INTERVENTIONAL NCT04178135

Recombinant LH Supplementation Timing Strategies (From Day 1 or Day 6) to a Standard GnRH Agonist Long Protocol in Subsequent COS Cycle of Older Patients With Unexpected Poor or Suboptimal Ovarian Response

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

A randomized, controlled, pilot study, for Patients ≥ 35 years and \< 40 years old with sufficient ovarian reserve parameters (AFC≥ 5), but showed an unexpected poor or suboptimal ovarian response(defined as ≤ 9 retrieved oocytes in previous full-stimulation cycle, but not get live birth after all embryos were used ). In order to get better oocyte number and quality in the new COS cycle, we will compare LH supplementation from beginning with from middle of stimulation in GnRH-a long protocol.

Interventions

Name: rLH
Type: DRUG
Description: rLH supplement from day 1 of stimulation
Name: rLH
Type: DRUG
Description: rLH supplement from day 6 of stimulation

Primary Outcomes

Measure: Number of gestational sacs
TimeFrame: Day 28 after embryo transfer
Description: Number of gestation sac will be detected by ultrasonographic visualization

Trial Information

NCT ID

NCT04178135

Status

Unknown

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

Reproductive & Genetic Hospital of CITIC-Xiangya

Last Updated

December 15, 2025